H
GILD icon

Hexavest’s Gilead Sciences GILD Stock Holding History

Hexavest’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-455,960
Closed -$35.2M – 409
2018
Q3 		$35.2M Sell
455,960
-19,398
-4% -$1.47M 0.45% 79
2018
Q2 		$33.7M Buy
475,358
+397
+0.1% +$28K 0.44% 81
2018
Q1 		$35.8M Sell
474,961
-1,077
-0.2% -$85.6K 0.45% 76
2017
Q4 		$34.1M Buy
476,038
+5,449
+1% +$414K 0.39% 87
2017
Q3 		$38.1M Buy
470,589
+7,590
+2% +$580K 0.47% 67
2017
Q2 		$32.8M Sell
462,999
-17,642
-4% -$1.17M 0.43% 78
2017
Q1 		$32.6M Buy
+480,641
New +$33.8M 0.39% 83

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Hexavest's GILD Position: Q4 2018 in Review

Hexavest sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 455,960 shares — an estimated $35.2M sold.

Hexavest first reported a position in GILD in Q1 2017 and held it in 7 quarters. The position peaked at $38.1M in Q3 2017. 1,498 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Hexavest reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Hexavest sold 455,960 Gilead Sciences shares in Q4 2018, an estimated $35.2M.
  • Hexavest first reported a position in Gilead Sciences in Q1 2017 and held it in 7 quarters.
  • Hexavest's Gilead Sciences position peaked at $38.1M in Q3 2017.
  • 1,498 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Hexavest's 13F filing for Q4 2018, filed 10 Jan 2019.